Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III or Stage IV Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01496807
What this trial is testing

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 31
Early research (Phase 1)Study completedNCT00090896
What this trial is testing

CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT03352947
What this trial is testing

Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma
Cambridge University Hospitals NHS Foundation Trust 79
Testing effectiveness (Phase 2)Study completedNCT06151847
What this trial is testing

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+1 more
University of Kansas Medical Center 11
Large-scale testing (Phase 3)Study completedNCT00110019
What this trial is testing

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IIIA Skin Melanoma+3 more
National Cancer Institute (NCI) 823
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00003339
What this trial is testing

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 48
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT00039000
What this trial is testing

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Who this might be right for
Malignant Melanoma
Agenus Inc. 350
Not applicableNo Longer AvailableNCT00495066
What this trial is testing

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Ended earlyNCT01701037
What this trial is testing

Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIB Melanoma (Locally Advanced)Stage IIC Melanoma (Locally Advanced)+4 more
Vanderbilt-Ingram Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245
What this trial is testing

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Who this might be right for
Unresectable Stage III MelanomaStage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Ended earlyNCT00961376
What this trial is testing

Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)

Who this might be right for
Melanoma
Providence Health & Services 5
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00525031
What this trial is testing

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT00540969
What this trial is testing

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)Study completedNCT00928902
What this trial is testing

Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
University of Virginia 41
Large-scale testing (Phase 3)Ended earlyNCT04588246
What this trial is testing

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more
NRG Oncology 19
Early research (Phase 1)Ended earlyNCT02200562
What this trial is testing

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

Who this might be right for
Stage III or IV Melanoma
University of Utah 6
Early research (Phase 1)Study completedNCT02141542
What this trial is testing

Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Metastatic Melanoma
F. Stephen Hodi, MD 15
Next Page